Odyssey Therapeutics, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | – | – | |
| – | +77.6% | +5.8% | -5.4% | |
| – | +13.5% | +38.7% | +64.9% | |
| – | – | -469.1% | – | |
| – | -61.2% | -84.9% | +61.3% | |
| – | – | – | – | |
| – | -197.6% | – | – | |
| – | -49.6% | -70.7% | +699.3% | |
| – | -365.9% | – | -375.1% | |
| – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.